Leap Therapeutics Inc. buy Rodman & Renshaw
Start price
28.06.24
/
50%
€1.64
Target price
28.06.25
€7.47
Performance (%)
-85.85%
End price
29.06.25
€0.23
Summary
This prediction ended on 29.06.25 with a price of €0.23. Massive losses of -85.85% were the result for the BUY prediction by Rodman___Renshaw. Rodman___Renshaw has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Leap Therapeutics Inc. | -11.139% | -11.139% | 125.000% |
| iShares Core DAX® | 0.080% | 8.288% | 12.701% |
| iShares Nasdaq 100 | 3.103% | 8.871% | 40.977% |
| iShares Nikkei 225® | -0.475% | 12.646% | 45.337% |
| iShares S&P 500 | 1.988% | 6.691% | 30.973% |
Comments by Rodman___Renshaw for this prediction
In the thread Leap Therapeutics Inc diskutieren
Leap Therapeutics, Inc. (NASDAQ: LPTX) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $8.00 price target on the stock.
Ratings data for LPTX provided by MarketBeat
In the thread Trading Leap Therapeutics Inc.
Die von Rodman___Renshaw gewählte maximale Laufzeit wurde überschritten